Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Miki, Saeki"'
Autor:
Marika Watanabe, Kimikazu Yakushijin, Hidekazu Tanaka, Ruri Chijiki, Miki Saeki, Yuri Hirakawa, Hidetomo Takakura, Yutaro Usui, Hiroya Ichikawa, Rina Sakai, Sakuya Matsumoto, Shigeki Nagao, Yu Mizutani, Keiji Kurata, Akihito Kitao, Yoshiharu Miyata, Yasuyuki Saito, Shinichiro Kawamoto, Katsuya Yamamoto, Mitsuhiro Ito, Hiroshi Matsuoka, Hironobu Minami
Publikováno v:
eJHaem, Vol 4, Iss 1, Pp 192-198 (2023)
Abstract Global longitudinal strain (GLS), a new cardiac parameter measured by the speckle‐tracking method, is reportedly more sensitive than ejection fraction (EF) in detecting slight cardiac dysfunction in heart failure patients. We validated the
Externí odkaz:
https://doaj.org/article/08a32acebcda49d394b984448e8e569a
Autor:
Marika Watanabe, Kimikazu Yakushijin, Yohei Funakoshi, Goh Ohji, Hiroya Ichikawa, Hironori Sakai, Wataru Hojo, Miki Saeki, Yuri Hirakawa, Sakuya Matsumoto, Rina Sakai, Shigeki Nagao, Akihito Kitao, Yoshiharu Miyata, Taiji Koyama, Yasuyuki Saito, Shinichiro Kawamoto, Katsuya Yamamoto, Mitsuhiro Ito, Tohru Murayama, Hiroshi Matsuoka, Hironobu Minami
Publikováno v:
Vaccines, Vol 10, Iss 11, p 1830 (2022)
We previously reported that a second dose of BNT162b2 was safe and effective for allogeneic hematopoietic stem cell transplantation (HSCT) patients. Here, we investigated the safety and efficacy of a third dose of COVID-19 mRNA vaccine in allogeneic
Externí odkaz:
https://doaj.org/article/5a227181112b4ce698897b6215a8aae4
Autor:
Marika Watanabe, Kimikazu Yakushijin, Yohei Funakoshi, Goh Ohji, Wataru Hojo, Hironori Sakai, Miki Saeki, Yuri Hirakawa, Sakuya Matsumoto, Rina Sakai, Shigeki Nagao, Akihito Kitao, Yoshiharu Miyata, Taiji Koyama, Yasuyuki Saito, Shinichiro Kawamoto, Mitsuhiro Ito, Tohru Murayama, Hiroshi Matsuoka, Hironobu Minami
Publikováno v:
Vaccines, Vol 10, Iss 2, p 158 (2022)
Patients who have undergone hematopoietic stem cell transplantation (HSCT) for hematological disease experience high mortality when infected by coronavirus disease 2019 (COVID-19). However, the safety and efficacy of the COVID-19 vaccine in HSCT pati
Externí odkaz:
https://doaj.org/article/59c227270e924badae1fa08cf75e03ce
Autor:
Marika Watanabe, Kimikazu Yakushijin, Hidekazu Tanaka, Ruri Chijiki, Miki Saeki, Yuri Hirakawa, Hidetomo Takakura, Yutaro Usui, Hiroya Ichikawa, Rina Sakai, Sakuya Matsumoto, Shigeki Nagao, Yu Mizutani, Keiji Kurata, Akihito Kitao, Yoshiharu Miyata, Yasuyuki Saito, Shinichiro Kawamoto, Katsuya Yamamoto, Mitsuhiro Ito, Hiroshi Matsuoka, Hironobu Minami
Publikováno v:
eJHaem. 4:192-198
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ba7f82042637a0f5881f75ad74de4e9
https://doi.org/10.1002/jha2.586
https://doi.org/10.1002/jha2.586
Autor:
Miki, Saeki, Kitagawa, Haruaki, Kitagawa, Ranna, Kiba, Wakako, Hayashi, Mikako, Imazato, Satoshi
Publikováno v:
In Dental Materials September 2016 32(9):1095-1102
Autor:
Yohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, Wataru Hojo, Hironori Sakai, Marika Watanabe, Miki Saeki, Yuri Hirakawa, Rina Sakai, Sakuya Matsumoto, Yu Mizutani, Akihito Kitao, Yoshiharu Miyata, Yasuyuki Saito, Shinichiro Kawamoto, Katsuya Yamamoto, Mitsuhiro Ito, Meiko Nishimura, Yoshinori Imamura, Naomi Kiyota, Hiroshi Matsuoka, Yasuko Mori, Hironobu Minami
Publikováno v:
International Journal of Hematology
We investigated the efficacy of BNT162b2 mRNA COVID-19 vaccine in patients with B-cell malignancies treated with anti-CD20 antibody. Although T-cell-mediated immune responses were detected even in patients receiving R-CHOP treatment, the S1 antibody
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12aceee6443e3e41b69c46f5870d520d
http://europepmc.org/articles/PMC8723797
http://europepmc.org/articles/PMC8723797
Autor:
Kitagawa, Haruaki, Takeda, Kahoru, Kitagawa, Ranna, Izutani, Naomi, Miki, Saeki, Hirose, Nanako, Hayashi, Mikako, Imazato, Satoshi
Publikováno v:
In Acta Biomaterialia October 2014 10(10):4285-4295
Autor:
Marika Watanabe, Kimikazu Yakushijin, Yohei Funakoshi, Goh Ohji, Hironori Sakai, Wataru Hojo, Miki Saeki, Yuri Hirakawa, Sakuya Matsumoto, Rina Sakai, Shigeki Nagao, Akihito Kitao, Yoshiharu Miyata, Taiji Koyama, Yasuyuki Saito, Shinichiro Kawamoto, Mitsuhiro Ito, Tohru Murayama, Hiroshi Matsuoka, Hironobu Minami
Patients who have undergone hematopoietic stem cell transplantation (HSCT) for hematological disease experience high mortality when infected by coronavirus disease 2019 (COVID-19). However, the safety and efficacy of COVID-19 vaccine in HSCT patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::287e95d1acbd1af33829e28551de534d
https://doi.org/10.1101/2021.12.28.21268477
https://doi.org/10.1101/2021.12.28.21268477
Autor:
Yasuyuki Saito, Kimikazu Yakushijin, Yoshiharu Miyata, Sakuya Matsumoto, Yohei Funakoshi, Yu Mizutani, Wataru Hojo, Yoshinori Imamura, Yasuko Mori, Miki Saeki, Yamamoto Katsuya, Mitsuhiro Ito, Naomi Kiyota, Yuri Hirakawa, Meiko Nishimura, Akihito Kitao, Hironobu Minami, Hiroshi Matsuoka, Shinichiro Kawamoto, Goh Ohji, Marika Watanabe, Rina Sakai, Hironori Sakai
Publikováno v:
Blood
COVID-19, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has become a global pandemic. Patients with hematological disorders are known to be at high risk of morbidity and mortality from COVID-19, and vaccines against SARS-CoV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::961c3383fc05de850358f32906812e33
https://doi.org/10.1182/blood-2021-148981
https://doi.org/10.1182/blood-2021-148981